Sinovac BiotechSVA
13F holders, Q4 2025 (December 31)28holders +1
1new positions
0sold out
1famous investor
$21.45avg. 13F price*
At the end of Q4 2025, 28 institutions reported holding Sinovac Biotech Ltd. (SVA) in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were Orbimed Advisors LLC ($184.5M), Vivo Capital, LLC ($38.2M) and Neumann Advisory Hong Kong Ltd ($2.0M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Sinovac Biotech Ltd.
- CUSIP
- P8696W104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 7,741 shares bought and 715 shares sold, net +7,026 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Orbimed Advisors LLC | 3.78% | No change | 2,718,735 | $184.5M |
| Vivo Capital, LLC | 2.47% | No change | 5,903,000 | $38.2M |
| Neumann Advisory Hong Kong Ltd | 0.54% | No change | 315,586 | $2.0M |
| Wells Fargo & Company | 0.00% | No change | 16,876 | $109K |
| Susquehanna International Group, LLP | 0.00% | No change | 16,430 | $106K |
| UBS Group AG | 0.00% | Add +315.0% | 9,222 | $60K |
| Morgan Stanley | 0.00% | No change | 9,144 | $59K |
| Aprio Wealth Management, LLC | 0.00% | New | 439 | $3K |
| Horizon Investments, LLC | 0.00% | No change | 52 | $336 |
| Bank of America Corp. | 0.00% | No change | 5,886 | $0 |
| Jones Financial Companies LLLP | 0.00% | Add +789.5% | 338 | $0 |
| Clearstead Advisors, LLC | 0.00% | No change | 500 | $0 |
| Navellier & Associates Inc. | 0.00% | Reduce -4.0% | 13,018 | $0 |
| California Public Employees Retirement System | 0.00% | No change | 68,732 | $0 |
| Royal Bank of Canada | 0.00% | No change | 425 | $0 |
| Renaissance Technologies | 0.00% | No change | 1,312,520 | $0 |
| MAI Capital Management | 0.00% | No change | 3 | $0 |
| Geode Capital Management, LLC | 0.00% | No change | 27,717 | $0 |
| Assetmark, Inc. | 0.00% | Add +8.3% | 26 | $0 |
| Transamerica Financial Advisors, LLC | 0.00% | Reduce -50.0% | 1 | $0 |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 424 | $0 |
| Skandinaviska Enskilda Banken AB (publ) | 0.00% | No change | 40,000 | $0 |
| Spark Investment Management LLC | 0.00% | No change | 29,100 | $0 |
| Financial Consulate, Inc. | 0.00% | No change | 23 | $0 |
| IFP Advisors, Inc | 0.00% | No change | 200 | $0 |
| Osaic Holdings, Inc. | 0.00% | Reduce -7.6% | 1,988 | $0 |
| Financial Gravity Asset Management, Inc. | 0.00% | No change | 23 | $0 |
| Atlantic Edge Private Wealth Management, LLC | 0.00% | No change | 1,000 | $0 |
"% of holder's portfolio" is SVA's weight in each manager's 13F, not the share of Sinovac Biotech Ltd. the manager owns.